Draft:Tissue engineering

Jellagen Announces Seed Financing to Develop Advanced Collagen Products for Therapeutic and Medical Device Applications

Retrieved on: 
Thursday, June 25, 2020
Biotechnology, Health, Medical Supplies, Medical devices, Branches of biology, Articles, Physiology, Collagen, Biomaterial, Healing, Type I collagen, Draft:Tissue engineering

Jellagen, a leader in advanced collagen biomaterials from marine sources, announces the closing of a 1.9m seed equity round to pursue development of products for therapeutic and medical device applications.

Key Points: 
  • Jellagen, a leader in advanced collagen biomaterials from marine sources, announces the closing of a 1.9m seed equity round to pursue development of products for therapeutic and medical device applications.
  • The round, which was 75% funded by international investors, will enable Jellagen to develop and partner pipeline products aimed at tissue reconstruction, diabetic wound care management and rare skin applications.
  • In the medical field, collagen is used in a range of procedures including tissue reconstruction and wound management.
  • Jellagen sources its collagen from a single species of jellyfish which not only avoids these risks but also delivers superior healing benefits in human applications.

Growing Number of Patients Suffering From Neurological Disorder to Support the Growth of Global Autologous Cell Therapy Market, TMR

Retrieved on: 
Monday, May 11, 2020
Branches of biology, Life sciences, Articles, Stem cells, Biotechnology, Cell biology, Transplantation medicine, Cell therapy, Therapy, Autotransplantation, Draft:Tissue engineering

As per a recent analysis by Transparency Market Research over pharmaceutical sector, it was found that the global autologous cell therapy market is witnessing a major push.

Key Points: 
  • As per a recent analysis by Transparency Market Research over pharmaceutical sector, it was found that the global autologous cell therapy market is witnessing a major push.
  • The major challenge that might impede the growth of global autologous cell therapy market is the cost of the therapy.
  • However, due to this the new players are unable to enter the global autologous cell therapy market.
  • The global autologous cell therapy market is segmented in the basis of:
    Global Autologous Cell Therapy Market, by Source

Growing Number of Patients Suffering From Neurological Disorder to Support the Growth of Global Autologous Cell Therapy Market, TMR

Retrieved on: 
Monday, May 11, 2020
Branches of biology, Life sciences, Articles, Stem cells, Biotechnology, Cell biology, Transplantation medicine, Cell therapy, Therapy, Autotransplantation, Draft:Tissue engineering

As per a recent analysis by Transparency Market Research over pharmaceutical sector, it was found that the global autologous cell therapy market is witnessing a major push.

Key Points: 
  • As per a recent analysis by Transparency Market Research over pharmaceutical sector, it was found that the global autologous cell therapy market is witnessing a major push.
  • The major challenge that might impede the growth of global autologous cell therapy market is the cost of the therapy.
  • However, due to this the new players are unable to enter the global autologous cell therapy market.
  • The global autologous cell therapy market is segmented in the basis of:
    Global Autologous Cell Therapy Market, by Source

Outlook on the Worldwide Medical Devices Testing Services Industry to 2029 - Analysis and Forecast - ResearchAndMarkets.com

Retrieved on: 
Friday, April 24, 2020
Medical devices, Health, Medical device, Draft:Tissue engineering

This report constitutes an in-depth study of the global medical devices testing services market, including a thorough analysis of different types of tests that are conducted for medical devices testing.

Key Points: 
  • This report constitutes an in-depth study of the global medical devices testing services market, including a thorough analysis of different types of tests that are conducted for medical devices testing.
  • Key Questions Answered in this Report:
    What are the key regulations abiding the development, commercialization, and clinical use of medical devices testing services across different regions?
  • What is the current annual demand for the global medical devices testing services across different regions and its growth potential in the forecast period?
  • What is the current market potential of medical devices testing services, and what are the factors deciding the growth potential of medical devices testing services in the forecast period?

Global Tissue Engineering Market (2019 to 2027) - Analysis and Forecasts by Tissue Type, Application and Geography - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 22, 2020
Biotechnology, Health, Surgery, Other Health, Tissue engineering, Biological engineering, Draft:Tissue engineering, Stem cells, Biomaterials

The "Tissue Engineering Market to 2027 - Global Analysis and Forecasts by Tissue Type; Application, and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Tissue Engineering Market to 2027 - Global Analysis and Forecasts by Tissue Type; Application, and Geography" report has been added to ResearchAndMarkets.com's offering.
  • Driving factors of the tissue engineering market are increasing incidences of chronic diseases, road accidents, and trauma injuries, as well as technological advancements in the field of 3D tissue engineering.
  • However, high cost of treatments related to tissue engineering is expected to restrain the growth of the market during the forecast period.
  • Moreover, the increasing government funding for research activities is expected to enhance the growth of the tissue engineering market.

Avectas Announces Issuance of U.S. Patent for Cell Engineering Technology by the U.S. Patent and Trademark Office

Retrieved on: 
Wednesday, April 8, 2020
Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Cell biology, Cell therapy, United States Patent and Trademark Office, Draft:Tissue engineering, Cell encapsulation

DUBLIN, April 8, 2020 /PRNewswire/ --Avectas announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No.

Key Points: 
  • DUBLIN, April 8, 2020 /PRNewswire/ --Avectas announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No.
  • Avectas is a cell engineering technology business developing a unique delivery platform to enable the ex-vivo manufacture of gene-modified cell therapy products, which retain high in-vivo functionality.
  • Avectas' Solupore cell engineering technology has been developed to address challenges encountered with the manufacture of autologous and allogeneic cellular therapy products.
  • We look forward to continuing the development of Solupore to address the tremendous need for a new cell engineering technology for next-generation cell therapies."

Avectas Announces Issuance of U.S. Patent for Cell Engineering Technology by the U.S. Patent and Trademark Office

Retrieved on: 
Wednesday, April 8, 2020
Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Cell biology, Cell therapy, United States Patent and Trademark Office, Draft:Tissue engineering, Cell encapsulation

DUBLIN, April 8, 2020 /PRNewswire/ --Avectas announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No.

Key Points: 
  • DUBLIN, April 8, 2020 /PRNewswire/ --Avectas announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No.
  • Avectas is a cell engineering technology business developing a unique delivery platform to enable the ex-vivo manufacture of gene-modified cell therapy products, which retain high in-vivo functionality.
  • Avectas' Solupore cell engineering technology has been developed to address challenges encountered with the manufacture of autologous and allogeneic cellular therapy products.
  • We look forward to continuing the development of Solupore to address the tremendous need for a new cell engineering technology for next-generation cell therapies."

Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

Retrieved on: 
Wednesday, March 25, 2020
Branches of biology, Biology, Life sciences, Stem cells, Induced stem cells, Biotechnology, Cell biology, Developmental biology, Stem-cell therapy, Draft:Tissue engineering

What is the market size of Autologous Stem Cell & Non-Stem Cell Based Therapies market in the Global?

Key Points: 
  • What is the market size of Autologous Stem Cell & Non-Stem Cell Based Therapies market in the Global?
  • What are the factors that affect the growth in the Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market over the forecast period?
  • What is the competitive position in the Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
  • What are the modes of entering the Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market?

The global digital therapeutics market was valued at $2,238 million in 2018 and is expected to reach $9,640 million by 2026

Retrieved on: 
Monday, March 9, 2020
Articles, Health informatics, Behavior modification, Digital therapeutics, Life sciences, Health, Draft:Tissue engineering

Digital therapeutics software application can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes.

Key Points: 
  • Digital therapeutics software application can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes.
  • However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the market growth.
  • The global digital therapeutics market is segmented into application, product type, sales channel, and region.
  • - A comprehensive analysis of the factors that drive and restrain the growth of the global digital therapeutics market is provided.

2-Day Seminar: Drug/Device and Device/Drug Combinations in the EU and USA 20 (London, UK - April 2-3, 2020) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 4, 2020
Pharmaceutical, Health, Medical devices, Health, Articles, Clinical research, Pharmaceuticals policy, Clinical trials, Pharmaceutical industry, Food and Drug Administration, United States Public Health Service, Medical device, Postmarketing surveillance, Draft:Tissue engineering, Medical software

The "Drug/Device and Device/Drug Combinations in the EU and USA 20" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Drug/Device and Device/Drug Combinations in the EU and USA 20" conference has been added to ResearchAndMarkets.com's offering.
  • This seminar will address the European and FDA regulatory requirements, help you define the regulatory route for your product and offer practical guidance on Notified Body expectations, clinical trial considerations and post-market surveillance of borderline products.
  • Participants will have an invaluable opportunity to discuss the complex issues involved with key regulatory experts in this field.
  • At the same time, cell therapy and tissue-engineered products are being combined with both pharmaceuticals and medical devices.